Sponsor Pipeline

Suzhou Alphamab Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
4
Recruiting
3
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2
2
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07545395 Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Hemophilia A or B Recruiting
NCT06312475 Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With… Hemophilia A With Inhibitor Active, Not Recruiting
NCT06569108 Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without… Hemophilia A Without Inhibitor Active, Not Recruiting
Phase 2
NCT06747416 KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without… Hemophilia a and B Not Yet Recruiting
NCT06180889 Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing… Knee Arthroplasty, Total Active, Not Recruiting
Phase 1/2
NCT07201467 To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in… End-Stage Renal Disease Requiring Haemodialysis Recruiting
Phase 1
NCT06547775 A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight Overweight or Obesity Recruiting
NCT07191899 To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension Hypertension Recruiting
Disease Areas
Get alerts when Suzhou Alphamab Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free